DavidH.SachsMD
Allergy & Immunology • Boston, MAClinical & Laboratory Immunology
Professor, Surgery, Massachusetts General Hospital, Harvard Medical School
Dr. Sachs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bldg. 149-9019, 13th Street
Boston, MA 02129Phone+1 617-726-4065Fax+1 617-726-4067
Education & Training
Massachusetts General HospitalInternship, Transitional Year, 1968 - 1969
Harvard Medical SchoolClass of 1968
Certifications & Licensure
MA State Medical License 1987 - 2026
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1996
Clinical Trials
- Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant Start of enrollment: 2003 Jun 01
- Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection Start of enrollment: 2008 Dec 01
- Renal Allograft Tolerance Through Mixed Chimerism Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 289 citationsThe promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K. Lewis, Luis M. Alvarez, Robert Langer, Alvin E. Roth
Nature Biotechnology. 2017-06-01 - 529 citationsHeart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience.Kenji Kuwaki, Yau Lin Tseng, Frank J. M. F. Dor, Akira Shimizu, Stuart L. Houser
Nature Medicine. 2005-01-01 - 72 citationsLong-term survival of influenza virus infected club cells drives immunopathologyNicholas S. Heaton, Ryan A. Langlois, David H. Sachs, Jean K. Lim, Peter Palese
The Journal of Experimental Medicine. 2014-08-25
Journal Articles
- Ontak-like Human IL-2 Fusion ToxinDavid H. Sachs, Joren C. Madsen, Joren C Madsen, David H Sachs, ScienceDirect
Press Mentions
Healthy ConversationsMarch 23rd, 2022- UCLA Health Advances Pioneering Protocol to Enable Transplant Recipients to Thrive Without Antirejection DrugsFebruary 1st, 2022
- Four Breakthroughs That Led to the Pig Heart TransplantJanuary 18th, 2022
- Join now to see all
Grant Support
- Thymic Rejuvenation For The Induction Of Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2010–2012
- Tolerance Induction In A Galt-Ko Pig-To-Baboon Model Through Mixed ChimerismNational Institute Of Allergy And Infectious Diseases2011
- Galt-Ko Pigs Expressing Primate CD47 To Facilitate Organ XenograftsNational Institute Of Allergy And Infectious Diseases2010–2011
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
- Tolerance To Composite Islet-Kidney Transplants In BaboonsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Tolerance To Vascularized Allografts In MiniswineNational Institute Of Allergy And Infectious Diseases2006–2011
- A Tolerance Approach To XenotransplantationNational Institute Of Allergy And Infectious Diseases2001–2011
- Training In Transplantation BiologyNational Institute Of Allergy And Infectious Diseases1998–2011
- Genetics And Mechanisms Of DLI Effects Following Non-Myeloblative HCTNational Cancer Institute2010
- Genetics And Mechanisms Of DLI Effects Following Non-Myeloblative HCTNational Cancer Institute2006–2009
- Tolerance Induction In A Gait-Ko Pig-To-Baboon Model Through Establishment ......National Institute Of Allergy And Infectious Diseases2005–2009
- Tolerance Induction In A Galt-Ko Pig-To-Baboon Model Through Establishment Of MIXNational Institute Of Allergy And Infectious Diseases2007
- Islet-Kidney Transplants For Treatment Of Diabetic ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Tolerance To Vascularized Allografts In MiniswineNational Institute Of Allergy And Infectious Diseases1996–2005
- Islet-Kidney Transplants For Treatment Of Diabetic ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
- Xenograft Tolerance Through Mixed ChimerismNational Institute Of Allergy And Infectious Diseases2000–2002
- Mixed Chimerism In Miniature SwineNational Cancer Institute2000–2002
- Mixed Hematopoietic Cell Chimerism In A ModelNational Heart, Lung, And Blood Institute1999–2002
- Tolerance To Heart Transplants In Miniature SwineNational Heart, Lung, And Blood Institute1998–2002
- Thymus TransplantationNational Institute Of Allergy And Infectious Diseases1996–2002
- Bone Marrow Culture And Engraftment In A Swine ModelNational Heart, Lung, And Blood Institute1995–1999
- Transplantation Of T Cell-Depleted Marrow In MiniswineNational Cancer Institute1994–1997
- Retroviral Transduction Of Class I MHC GeneNational Heart, Lung, And Blood Institute1993–1997
- Tolerance To Vascular AllograftsNational Institute Of Allergy And Infectious Diseases1994–1995
- Bone Marrow Transplantation Across MHC BarriersNational Cancer Institute1992–1994
- Bone Marrow Culture And Engraftment In A ModelNational Heart, Lung, And Blood Institute1991–1994
- Tolerance To Vascular Allografts In Miniature SwineNational Institute Of Allergy And Infectious Diseases1991–1993
- A Flexible Scheduling Program For Longitudinal StudiesNational Institute On Drug Abuse1991
- Optimum Dose And Schedule For Nicotine Gum TreatmentNational Institute On Drug Abuse1988–1991
- A Flexible Scheduling Program For Longitudinal StudiesNational Institute On Drug Abuse1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
